CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 78.1% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
3.13
0.32%
Market Trading Hours* (UTC) Opens on Wednesday at 07:00

Mon - Fri: 07:00 - 15:30

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
Trading сonditions
Spread 0.07
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.022099 %
Charges from full value of position ($-4.20)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.022099%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.000123 %
Charges from full value of position ($-0.02)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.000123%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency EUR
Margin 5%
Stock exchange Spain
Commission on trade 0%

*Information provided by Capital.com

Faes Farma SA ESG Risk Ratings

High Medium Low Negligible

‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 3.14
Open* 3.13
1-Year Change* N/A
Day's Range* 3.1 - 3.13
52 wk Range 2.87-3.57
Average Volume (10 days) 171.89K
Average Volume (3 months) 4.14M
Market Cap 981.88M
P/E Ratio 10.85
Shares Outstanding 308.58M
Revenue 448.73M
EPS 0.29
Dividend (Yield %) 5.05636
Beta 0.56
Next Earnings Date Feb 26, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Apr 16, 2024 3.13 0.03 0.97% 3.10 3.14 3.10
Apr 15, 2024 3.14 0.03 0.96% 3.11 3.16 3.07
Apr 12, 2024 3.14 -0.01 -0.32% 3.15 3.15 3.08
Apr 11, 2024 3.15 0.06 1.94% 3.09 3.16 3.09
Apr 10, 2024 3.12 -0.02 -0.64% 3.14 3.16 3.11
Apr 9, 2024 3.09 -0.02 -0.64% 3.11 3.16 3.09
Apr 8, 2024 3.11 0.04 1.30% 3.07 3.12 3.07
Apr 5, 2024 3.09 -0.03 -0.96% 3.12 3.12 3.09
Apr 4, 2024 3.14 0.02 0.64% 3.12 3.16 3.10
Apr 3, 2024 3.11 0.00 0.00% 3.11 3.13 3.10
Apr 2, 2024 3.12 0.02 0.65% 3.10 3.15 3.10
Mar 28, 2024 3.13 0.01 0.32% 3.12 3.15 3.12
Mar 27, 2024 3.14 -0.01 -0.32% 3.15 3.17 3.11
Mar 26, 2024 3.15 0.03 0.96% 3.12 3.17 3.12
Mar 25, 2024 3.17 0.06 1.93% 3.11 3.17 3.11
Mar 22, 2024 3.12 0.09 2.97% 3.03 3.13 3.03
Mar 21, 2024 3.05 0.11 3.74% 2.94 3.05 2.94
Mar 20, 2024 2.94 0.01 0.34% 2.93 2.95 2.88
Mar 19, 2024 2.93 0.02 0.69% 2.91 2.95 2.89
Mar 18, 2024 2.91 0.00 0.00% 2.91 2.93 2.89

Faes Farma, S.A. Events

Time (UTC) Country Event
Wednesday, April 24, 2024

Time (UTC)

10:59

Country

ES

Event

Q1 2024 Faes Farma SA Earnings Release
Q1 2024 Faes Farma SA Earnings Release

Forecast

-

Previous

-
Thursday, June 13, 2024

Time (UTC)

11:00

Country

ES

Event

Faes Farma SA Annual Shareholders Meeting
Faes Farma SA Annual Shareholders Meeting

Forecast

-

Previous

-
Friday, July 26, 2024

Time (UTC)

10:59

Country

ES

Event

Half Year 2024 Faes Farma SA Earnings Release
Half Year 2024 Faes Farma SA Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total revenue 438.754 398.557 380.24 357.398 324.312
Revenue 438.754 398.557 380.24 357.398 324.312
Cost of Revenue, Total 156.739 146.16 140.403 129.988 120.178
Gross Profit 282.015 252.397 239.837 227.41 204.134
Total Operating Expense 337.271 305.302 293.469 282.539 262.339
Selling/General/Admin. Expenses, Total 117.013 109.108 107.108 105.25 95.904
Research & Development 3.716 3.888 3.246 4.175 2.821
Depreciation / Amortization 19.271 17.257 14.826 12.533 10.254
Unusual Expense (Income) 0.439 3.858 5.54 4.118 0.035
Other Operating Expenses, Total 40.093 25.031 22.346 26.475 33.147
Operating Income 101.483 93.255 86.771 74.859 61.973
Interest Income (Expense), Net Non-Operating -0.315 -0.312 -2.045 -0.743 -0.318
Other, Net 0.253 0.023 0.156 0.059 0.076
Net Income Before Taxes 101.421 92.966 84.882 74.175 61.731
Net Income After Taxes 89.502 82.446 73.376 64.026 51.8
Net Income Before Extra. Items 89.55 82.39 72.549 63.962 51.592
Net Income 89.55 82.39 72.549 63.962 51.592
Income Available to Common Excl. Extra. Items 89.55 82.39 72.549 63.962 51.592
Income Available to Common Incl. Extra. Items 89.55 82.39 72.549 63.962 51.592
Diluted Net Income 89.55 82.39 72.549 63.962 51.592
Diluted Weighted Average Shares 316.631 329.674 316.325 316.795 317.846
Diluted EPS Excluding Extraordinary Items 0.28282 0.24991 0.22935 0.2019 0.16232
Dividends per Share - Common Stock Primary Issue 0.03382 0.0508 0.01896
Diluted Normalized EPS 0.28404 0.26029 0.24449 0.21312 0.16241
Minority Interest 0.048 -0.056 -0.827 -0.064 -0.208
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total revenue 107.079 117.755 118.45 105.444 102.31
Revenue 107.079 117.755 118.45 105.444 102.31
Cost of Revenue, Total 113.581 38.934 39.149 37.368 38.892
Gross Profit -6.502 78.821 79.301 68.076 63.418
Total Operating Expense 81.613 88.367 85.902 90.21 77.92
Selling/General/Admin. Expenses, Total 20.739 25.113 26.286 25.154 19.133
Depreciation / Amortization 4.997 4.862 4.61 4.884 5.292
Other Operating Expenses, Total -57.704 19.458 15.857 22.365 14.603
Operating Income 25.466 29.388 32.548 15.234 24.39
Interest Income (Expense), Net Non-Operating 0.263 0.028 -0.238
Net Income Before Taxes 25.373 29.651 32.576 14.996 24.197
Net Income After Taxes 21.106 25.303 27.679 15.468 20.979
Net Income Before Extra. Items 21.16 25.385 27.615 15.557 21.086
Net Income 21.16 25.385 27.615 15.557 21.086
Income Available to Common Excl. Extra. Items 21.16 25.385 27.615 15.557 21.086
Income Available to Common Incl. Extra. Items 21.16 25.385 27.615 15.557 21.086
Diluted Net Income 21.16 25.385 27.615 15.557 21.086
Diluted Weighted Average Shares 326.299 299.054 316.71 316.394 317.765
Diluted EPS Excluding Extraordinary Items 0.06485 0.08488 0.08719 0.04917 0.06636
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS 0.06485 0.08488 0.08719 0.05007 0.06636
Minority Interest 0.054 0.082 -0.064 0.089 0.107
Unusual Expense (Income) 0.439
Total Adjustments to Net Income
Other, Net -0.093 -0.193
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Total Current Assets 313.211 293.711 290.007 222.989 217.581
Cash and Short Term Investments 84.1 73.408 93.136 54.183 76.409
Cash & Equivalents 66.411 70.254 91.21 52.853 76.038
Short Term Investments 17.689 3.154 1.926 1.33 0.371
Total Receivables, Net 113.593 112.492 104.905 96.813 81.537
Accounts Receivable - Trade, Net 101.168 101.489 98.773 90.476 77.061
Total Inventory 115 107.451 91.591 71.454 59.305
Prepaid Expenses 0.518 0.36 0.375 0.539 0.33
Total Assets 725.67 645.114 581.517 493.673 471.204
Property/Plant/Equipment, Total - Net 205.804 139.628 95.245 83.932 67.057
Property/Plant/Equipment, Total - Gross 288.209 216.569 167.531 150.913 129.674
Accumulated Depreciation, Total -82.405 -76.941 -72.286 -66.981 -62.617
Goodwill, Net 51.776 53.33 52.643 61.503 53.941
Intangibles, Net 126.911 129.431 112.88 106.99 111.737
Long Term Investments 6.682 2.54 1.888 2.01 1.881
Other Long Term Assets, Total 21.286 26.474 28.854 16.249 19.007
Total Current Liabilities 94.428 79.307 84.685 72.279 103.751
Accounts Payable 36.594 37.925 41.973 36.185 35.644
Accrued Expenses 12.002 11.97 13.349 11.721 10.918
Notes Payable/Short Term Debt 11.322 7.437 4.932 0 0
Other Current Liabilities, Total 17.547 15.129 17.115 17.022 9.479
Total Liabilities 124.594 109.304 110.122 80.705 111.321
Total Long Term Debt 4.4 2.161 1.645 3.18 0.885
Long Term Debt 0.003 0.013 0.062 0.379 0.885
Minority Interest 1.203 1.538 1.482 0.686 0.271
Other Liabilities, Total 4.821 4.599 4.943 4.56 6.414
Total Equity 601.076 535.81 471.395 412.968 359.883
Common Stock 31.078 29.742 28.524 27.815 27.009
Additional Paid-In Capital 1.46 1.46 1.46 1.46 1.46
Retained Earnings (Accumulated Deficit) 579.087 512.934 449.164 388.955 336.687
Treasury Stock - Common -5.264 -5.264 -5.264 -5.264 -5.264
Other Equity, Total -5.285 -3.062 -2.489 0.002 -0.009
Total Liabilities & Shareholders’ Equity 725.67 645.114 581.517 493.673 471.204
Total Common Shares Outstanding 316.71 316.75 316.778 316.795 307.642
Current Port. of LT Debt/Capital Leases 16.963 6.846 7.316 7.351 47.71
Capital Lease Obligations 4.397 2.148 1.583 2.801 0
Deferred Income Tax 19.742 21.699 17.367
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 299.016 313.211
Cash and Short Term Investments 46.515 84.1
Cash & Equivalents 34.301 66.411
Short Term Investments 12.214 17.689
Total Receivables, Net 120.557 114.111
Accounts Receivable - Trade, Net 120.557 114.111
Total Inventory 131.944 115
Total Assets 756.543 725.67
Property/Plant/Equipment, Total - Net 248.788 205.804
Intangibles, Net 182.213 178.687
Long Term Investments 5.16 6.682
Other Long Term Assets, Total 21.366 21.286
Total Current Liabilities 81.567 94.428
Accounts Payable 36.594
Notes Payable/Short Term Debt 0 11.322
Current Port. of LT Debt/Capital Leases 5.903 16.963
Other Current Liabilities, Total 16.585 17.547
Total Liabilities 111.848 124.594
Total Long Term Debt 5.034 4.4
Long Term Debt 0 0.003
Capital Lease Obligations 5.034 4.397
Minority Interest 1.185 1.203
Other Liabilities, Total 4.415 4.821
Total Equity 644.695 601.076
Common Stock 32.167 31.078
Additional Paid-In Capital 1.46 1.46
Retained Earnings (Accumulated Deficit) 627.696 579.087
Treasury Stock - Common -14.13 -5.264
Other Equity, Total -2.498 -5.285
Total Liabilities & Shareholders’ Equity 756.543 725.67
Total Common Shares Outstanding 314.021 316.71
Accrued Expenses 12.002
Deferred Income Tax 19.647 19.742
Payable/Accrued 59.079
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line 89.502 83.213 73.376 64.026 51.8
Cash From Operating Activities 106.788 79.645 78.489 67.585 59.336
Cash From Operating Activities 19.271 16.235 14.826 12.679 10.254
Non-Cash Items 16.411 16.55 25.779 21.447 13.796
Cash Taxes Paid 7.131 9.224 5.69 5.494 4.949
Cash Interest Paid 0.263 0.216 0.266 0.051 0.256
Changes in Working Capital -18.396 -36.353 -35.492 -30.567 -16.514
Cash From Investing Activities -92.172 -83.485 -25.782 -34.034 -19.551
Capital Expenditures -80.948 -59.417 -25.723 -21.404 -19.514
Other Investing Cash Flow Items, Total -11.224 -24.068 -0.059 -12.63 -0.037
Cash From Financing Activities -18.459 -17.116 -14.35 -56.736 -7.016
Financing Cash Flow Items -0.312 -1.947 0.458 0.358 3.18
Total Cash Dividends Paid -18.147 -13.719 -12.235 -10.338 -7.547
Issuance (Retirement) of Stock, Net 0 -0.092 -2.834 -1.58
Issuance (Retirement) of Debt, Net 0 -1.45 -2.481 -43.922 -1.069
Net Change in Cash -3.843 -20.956 38.357 -23.185 32.769
Dec 2022 Sep 2022 Jun 2022 Mar 2022 Dec 2021
Net income/Starting Line 89.502 53.055 83.213
Cash From Operating Activities 106.788 61.219 79.645
Cash From Operating Activities 19.271 9.095 16.235
Non-Cash Items 16.411 10.583 16.55
Cash Taxes Paid 7.131 3.474 9.224
Cash Interest Paid 0.263 0.089 0.216
Changes in Working Capital -18.396 -11.514 -36.353
Cash From Investing Activities -92.172 -36.157 -83.485
Capital Expenditures -80.948 -36.187 -59.417
Other Investing Cash Flow Items, Total -11.224 0.03 -24.068
Cash From Financing Activities -18.459 -18.707 -17.116
Financing Cash Flow Items -0.312 -1.15 -1.947
Total Cash Dividends Paid -18.147 -18.147 -13.719
Issuance (Retirement) of Debt, Net 0 0.59 -1.45
Net Change in Cash -3.843 6.355 -20.956
Issuance (Retirement) of Stock, Net 0

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Faes Farma Company profile

About FAES Farma SA

Faes Farma SA is a Spain-based company engaged in the pharmaceutical industry. The Company specializes in the research, production, distribution and sale of prescription and generic drugs, over-the-counter (OTC) medicines, food supplements and personal care treatments, as well as raw materials for the pharmaceutical use. The Company’s research lines are mainly focused on the development of new drugs for the treatment of allergy, venous insufficiency and irritable bowel syndrome, among others. In addition, it provides animal nutrition products. The Company operates in Spain, Portugal, Chile and Mexico, among others. It controls a number of subsidiaries, such as Laboratorios Vitoria SA, Laboratorios Veris SA, Lazlo International SA, Ingaso Farm SLU, Esfion SA and Biotecnet I MAS D SA.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, FAES Farma SA revenues increased 5% to EUR398.6M. Net income increased 15% to EUR83.2M. Revenues reflect Speciality Pharmaceuticals segment increase of 5% to EUR336.8M, Nutrition & Animals Care Products segment increase of 6% to EUR60.3M, Domestic Market (Spain) segment increase of 11% to EUR307.3M. Net income benefited from Provisions decrease of 74% to EUR1.5M (expense).

Equity composition

05/2005, Scrip Issue, 1 new share for every 8 shares held. 03/2006, Scrip Issue, 1 new share for every 8 shares held. 01/2007, 2-for-1 stock split. 04/2007, Scrip Issue, 1 new share for every 8 shares held. 04/2008, Scrip Issue, 1 new share for every 8 shares held. 03/2009, Scrip Issue, 1 new share for every 8 shares held. => Note section

Industry: Pharmaceuticals (NEC)

Parque Empresarial Cristalia. Calle Vía de los Poblados 3, Edificio 2, 2º Izquierda
MADRID
MADRID 28033
ES

Income Statement

  • Annual
  • Quarterly

News

US Earnings Season : JP Morgan, Citigroup, Wells Fargo

The first major US banks report quarterly earnings on Friday, April 12th, 2024. We preview what to expect from JP Morgan, Citigroup, and Wells Fargo's quarterly numbers.

16:03, 11 April 2024

Reserve Bank of New Zealand Preview: Rates expected to remain on hold as inflation fight continues

The Reserve Bank of New Zealand (RBNZ) meets on Wednesday, April 10, 2024. We preview what to expect from the meeting and its possible impact on the NZD/USD.

09:22, 11 April 2024

US CPI Preview: US inflation expected to grind lower amid fears about sticky prices

US CPI data is released on Wednesday, 10 April. We preview what to expect from the data, how it could influence US Federal Reserve policy, and analyse the NASDAQ (US Tech 100).

15:11, 9 April 2024

How escalating geopolitical tensions are impacting oil markets

The bullish momentum in oil prices remains strong as escalating geopolitical tensions raise concerns about supply.

13:34, 4 April 2024

A way forward: a roundup of recent central bank decisions

Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.

12:47, 22 March 2024

Bank of Japan Preview: will the BOJ end negative interest rates?

The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.

08:44, 18 March 2024

Higher CPI leaves traders unfazed as US equities continue to build momentum

The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.

12:42, 15 March 2024

People also watch

US100

17,740.30 Price
+0.070% 1D Chg, %
Long position overnight fee -0.0262%
Short position overnight fee 0.0040%
Overnight fee time 21:00 (UTC)
Spread 1.8

ETH/USD

3,109.92 Price
+1.270% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 6.00

Gold

2,375.48 Price
-0.200% 1D Chg, %
Long position overnight fee -0.0191%
Short position overnight fee 0.0108%
Overnight fee time 21:00 (UTC)
Spread 0.30

BTC/USD

64,315.50 Price
+1.950% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 106.00

Still looking for a broker you can trust?

Join the 610,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading